Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.
| Revenue (Most Recent Fiscal Year) | $22.47M |
| Net Income (Most Recent Fiscal Year) | $-78.62M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 15.12 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.26 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -267.82% |
| Net Margin (Trailing 12 Months) | -267.92% |
| Return on Equity (Trailing 12 Months) | -283.78% |
| Return on Assets (Trailing 12 Months) | -62.85% |
| Current Ratio (Most Recent Fiscal Quarter) | 9.58 |
| Quick Ratio (Most Recent Fiscal Quarter) | 9.26 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.37 |
| Inventory Turnover (Trailing 12 Months) | 4.97 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.03 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.02 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.12 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.10 |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 814.68M |
| Free Float | 785.35M |
| Market Capitalization | $385.02M |
| Average Volume (Last 20 Days) | 5.60M |
| Beta (Past 60 Months) | 0.88 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.60% |
| Percentage Held By Institutions (Latest 13F Reports) | 12.36% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |